Matthew Bennett, MD
Anesthesiology · Pell City, ALNPI 1144205899
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 347 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,006 and has fallen 74.6% since, to $256 in 2025. Among anesthesiology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 347 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$899
- Boston Scientific$895
- Collegium Pharmaceutical, Inc.$540
- AbbVie$382
- Biodelivery Sciences International, Inc.$281
- Medtronic$208
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,105100%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 90 | $899 |
| Boston Scientific | 53 | $895 |
| Collegium Pharmaceutical, Inc. | 33 | $540 |
| AbbVie(2 entities) | 20 | $382 |
| Biodelivery Sciences International, Inc. | 20 | $281 |
| Medtronic(2 entities) | 12 | $208 |
| Scilex Pharmaceuticals Inc. | 14 | $206 |
| Almatica Pharma LLC | 12 | $199 |
| Indivior Inc. | 8 | $155 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $150 |
| Zyla Life Sciences, Inc. | 12 | $136 |
| Pfizer | 7 | $112 |
| Nevro Corp. | 6 | $85 |
| Arbor Pharmaceuticals, Inc. | 6 | $84 |
| Hikma Pharmaceuticals USA | 5 | $83 |
| Redhill Biopharma Inc. | 4 | $75 |
| Forte Bio-pharma LLC | 1 | $73 |
| Orexo US, Inc. | 5 | $70 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Si-bone, Inc. | 3 | $45 |
| Johnson & Johnson | 2 | $40 |
| Amgen(2 entities) | 3 | $40 |
| Braeburn Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Revance Therapeutics, Inc. | 1 | $27 |
| Vertex | 1 | $20 |
| Bioventus LLC | 1 | $19 |
| BD | 1 | $18 |
| Trevena, Inc. | 1 | $18 |
| Saluda Medical Americas, Inc. | 1 | $16 |
| Baudax Bio Inc. | 1 | $15 |
| MDD US Operations, LLC | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Sentynl Therapeutics, Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| GRT US Holding, Inc. | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| MML US, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,126 in reported general payments places this provider in the 95th percentile of 484 anesthesiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 81 | $43,073 |
| Buprenorphine | 142 | $32,445 |
| BelbucaBuprenorphine Hcl | 37 | $23,930 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 802 | $18,858 |
| ZtlidoLidocaine | 18 | $15,425 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 673 | $12,196 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 50 | $9,109 |
| LinzessLinaclotide | 13 | $7,008 |
| Lidocaine | 53 | $5,472 |
| Diclofenac Sodium | 123 | $3,905 |
| Gabapentin | 324 | $2,795 |
| Pregabalin | 127 | $2,659 |
| Naloxone Hcl | 29 | $1,893 |
| Tizanidine Hcl | 176 | $1,369 |
| Tramadol Hcl ErTramadol Hcl | 11 | $801 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $540 | $67,002118 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone | $83 | $41,553192 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $206 | $15,42518 claims |
| AbbVieLinzess | $382 | $7,00813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 484 anesthesiology providers in Alabama.
Other anesthesiology in Pell City
- Alexandru VisanBirmingham$138K
- Gregory HickmanBirmingham$134K
- Leslie FletcherHuntsville$35K
- Ursula WesselmannBirmingham$33K
- Keith JonesBirmingham$26K
- Clayton NewellHuntsville$17K
- Justin RoutmanBirmingham$16K
- Joshua SmithBirmingham$14K
- Prentiss LawsonBirmingham$13K
- Thomas ReganBirmingham$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.